Evidence map›Paper›PMID 32873697›Full record

ArticleGut2021

Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate.

Fons F van den Berg, Demi van Dalen, Sanjiv K Hyoju, Hjalmar C van Santvoort, Marc G Besselink, Willem Joost Wiersinga, Olga Zaborina, Marja A Boermeester, John Alverdy

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 2 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 2 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Antibiotic-associatedGut microbes · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Antioxidants (Basel, Switzerland) · 2025
    Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Fons F van den BergDepartment of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands f.f.vandenberg@amsterdamumc.nl.ORCID 0000-0001-6494-4287
Demi van DalenDepartment of Surgery, Radboudumc, Nijmegen, The Netherlands.
Sanjiv K HyojuDepartment of Surgery, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
Hjalmar C van SantvoortDepartment of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center, Utrecht, The Netherlands.
Marc G BesselinkDepartment of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
Willem Joost WiersingaCenter for Experimental and Molecular Medicine, Department of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-2277-1343
Olga ZaborinaDepartment of Surgery, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
Marja A BoermeesterDepartment of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
John AlverdyDepartment of Surgery, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
Amsterdam University Medical Centers · NLUniversity of Chicago · USRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 1990 to 2025
$29.8M
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERYR01GM062344 · NIGMS · UNIVERSITY OF CHICAGO · PI ALVERDY, JOHN C · 2001 to 2025
$9.2M
Probing short and long term consequences of Small and Large Bowel Microbiota Transplants on Host Physiology: Implications for the development of future live biotherapeuticsR01DK138072 · NIDDK · UNIVERSITY OF CHICAGO · PI EUGENE B CHANG, Kristina Brooke Martinez-Guryn · 2024 to 2026
$2.1M
NIDDK NIH HHS P30 DK042086NIDDK NIH HHS R01 DK138072NIGMS NIH HHS R01 GM062344
6 · The paper itself

Abstract

objectiveThe gut microbiota are the main source of infections in necrotising pancreatitis. We investigated the effect of disruption of the intestinal microbiota by a Western-type diet on mortality and bacterial dissemination in necrotising pancreatitis and its reversal by butyrate supplementation.

designC57BL/6 mice were fed either standard chow or a Western-type diet for 4 weeks and were then subjected to taurocholate-induced necrotising pancreatitis. Blood and pancreas were collected for bacteriology and immune analysis. The cecum microbiota composition of mice was analysed using 16S rRNA gene amplicon sequencing and cecal content metabolites were analysed by targeted (ie, butyrate) and untargeted metabolomics. Prevention of necrotising pancreatitis in this model was compared between faecal microbiota transplantation (FMT) from healthy mice, antibiotic decontamination against Gram-negative bacteria and oral or systemic butyrate administration. Additionally, the faecal microbiota of patients with pancreatitis and healthy subjects were analysed.

resultsMortality, systemic inflammation and bacterial dissemination were increased in mice fed Western diet and their gut microbiota were characterised by a loss of diversity, a bloom of

conclusionButyrate depletion and its repletion appear to play a central role in disease progression towards necrotising pancreatitis.

Indexed as

Diet, WesternAnimalsButyratesDisease Models, AnimalDisease ProgressionFecal Microbiota TransplantationGastrointestinal MicrobiomeHumansMiceMice, Inbred C57BLPancreatitis, Acute NecrotizingPhenotypeButyratesacute pancreatitisantibioticsbacterial infectionbutyratediet

Identifiers

PMID32873697
PMCPMC7917160
OpenAlexW3082902554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.